2,4,6-Tris(4-butoxy-2-hydroxyphenyl)-1,3,5-triazine>98.0%(HPLC)(N)1g

(S)-N-(1-(4-Bromophenyl)ethyl)-2,2,2-trifluoroacetamide, 97%, 100mg

Methyl 3-oxotetrahydrothiophene-2-carboxylate, 95.0%, 1g

(3-Fluoro-4-morpholinophenyl)boronic acid, 95.0%, 10g

Methyl 5-bromo-6-fluoronicotinate, 95.0%, 5g

Piperazin-1-yl-pyridin-3-yl-methanone, 1g

8-Bromo-2,3,4,5-tetrahydrobenzo[b]oxepin-5-amine, 97%, 100mg

(4-Isobutyrylphenyl)boronic acid, 95.0%, 100mg

Ethyl 4-(3-chlorophenyl)-2,4-dioxobutanoate, 95.0%, 5g

Porte-échantillon Louche cryogénique, 1 pièce

(S)-6-Amino-2-((S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido)hexanoic acid, 95.0%, 5g

(4S,5R)-3-((2S,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(tert-butoxy)butanoyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid, 97%, 10g

(R)-2-CYANOPYRROLIDINE TFA, 95.0%, 5g